Firebrick Pharma Limited (AU:FRE) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Firebrick Pharma Limited has successfully completed its Share Purchase Plan, raising $635,600 with the participation of around 100 shareholders, and anticipates an additional $158,700 from a Shortfall Placement. The capital raised, alongside recent RDTI funds, will be used to expand marketing for the company’s Nasodine® Nasal Spray in Singapore and the US, targeting healthcare professionals, pharmacy distributions, and marketing partnerships.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.